Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth (Q39675983)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth |
scientific article published on January 2011 |
Statements
1 reference
Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth (English)
1 reference
Begoña Martin-Castillo
1 reference
Alejandro Vazquez-Martin
1 reference
Cristina Oliveras-Ferraros
1 reference
Silvia Cufí
1 reference
Sonia Del Barco
1 reference
Javier A Menendez
1 reference
1 January 2011
1 reference
1 reference
226
1 reference
1
1 reference
52-57
1 reference
1 reference
Identifiers
1 reference
1 reference